221 related articles for article (PubMed ID: 1685937)
1. Brief treatment of sensory ganglion neurons with GM1 ganglioside enhances the efficacy of opioid excitatory effects on the action potential.
Shen KF; Crain SM; Ledeen RW
Brain Res; 1991 Sep; 559(1):130-8. PubMed ID: 1685937
[TBL] [Abstract][Full Text] [Related]
2. After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside.
Crain SM; Shen KF
Brain Res; 1992 Mar; 575(1):13-24. PubMed ID: 1324084
[TBL] [Abstract][Full Text] [Related]
3. Cholera toxin-B subunit blocks excitatory effects of opioids on sensory neuron action potentials indicating that GM1 ganglioside may regulate Gs-linked opioid receptor functions.
Shen KF; Crain SM
Brain Res; 1990 Oct; 531(1-2):1-7. PubMed ID: 1981160
[TBL] [Abstract][Full Text] [Related]
4. After GM1 ganglioside treatment of sensory neurons naloxone paradoxically prolongs the action potential but still antagonizes opioid inhibition.
Crain SM; Shen KF
J Pharmacol Exp Ther; 1992 Jan; 260(1):182-6. PubMed ID: 1731037
[TBL] [Abstract][Full Text] [Related]
5. Etorphine elicits anomalous excitatory opioid effects on sensory neurons treated with GM1 ganglioside or pertussis toxin in contrast to its potent inhibitory effects on naive or chronic morphine-treated cells.
Crain SM; Shen KF
Brain Res; 1996 Nov; 741(1-2):275-83. PubMed ID: 9001733
[TBL] [Abstract][Full Text] [Related]
6. Cholera toxin-A subunit blocks opioid excitatory effects on sensory neuron action potentials indicating mediation by Gs-linked opioid receptors.
Shen KF; Crain SM
Brain Res; 1990 Aug; 525(2):225-31. PubMed ID: 2174711
[TBL] [Abstract][Full Text] [Related]
7. GM1 ganglioside-induced modulation of opioid receptor-mediated functions.
Crain SM; Shen KF
Ann N Y Acad Sci; 1998 Jun; 845():106-25. PubMed ID: 9668346
[TBL] [Abstract][Full Text] [Related]
8. Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid 'dependence' without tolerance.
Shen KF; Crain SM
Brain Res; 1992 Nov; 597(1):74-83. PubMed ID: 1335822
[TBL] [Abstract][Full Text] [Related]
9. Nerve growth factor rapidly prolongs the action potential of mature sensory ganglion neurons in culture, and this effect requires activation of Gs-coupled excitatory kappa-opioid receptors on these cells.
Shen KF; Crain SM
J Neurosci; 1994 Sep; 14(9):5570-9. PubMed ID: 8083754
[TBL] [Abstract][Full Text] [Related]
10. Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence.
Shen KF; Crain SM
Brain Res; 1994 Feb; 636(2):286-97. PubMed ID: 8012813
[TBL] [Abstract][Full Text] [Related]
11. Opioids excite rather than inhibit sensory neurons after chronic opioid exposure of spinal cord-ganglion cultures.
Crain SM; Shen KF; Chalazonitis A
Brain Res; 1988 Jul; 455(1):99-109. PubMed ID: 2458169
[TBL] [Abstract][Full Text] [Related]
12. Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture.
Shen KF; Crain SM
Brain Res; 1989 Jul; 491(2):227-42. PubMed ID: 2548663
[TBL] [Abstract][Full Text] [Related]
13. Chronic opioid treatment of neuroblastoma x dorsal root ganglion neuron hybrid F11 cells results in elevated GM1 ganglioside and cyclic adenosine monophosphate levels and onset of naloxone-evoked decreases in membrane K+ currents.
Wu G; Fan SF; Lu ZH; Ledeen RW; Crain SM
J Neurosci Res; 1995 Nov; 42(4):493-503. PubMed ID: 8568936
[TBL] [Abstract][Full Text] [Related]
14. Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opioid analgesia and attenuating opioid tolerance/dependence.
Shen KF; Crain SM
Brain Res; 2001 Nov; 919(1):20-30. PubMed ID: 11689159
[TBL] [Abstract][Full Text] [Related]
15. Specific N- or C-terminus modified dynorphin and beta-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists.
Shen KF; Crain SM
Brain Res; 1995 Feb; 673(1):30-8. PubMed ID: 7757476
[TBL] [Abstract][Full Text] [Related]
16. Biphalin, an enkephalin analog with unexpectedly high antinociceptive potency and low dependence liability in vivo, selectively antagonizes excitatory opioid receptor functions of sensory neurons in culture.
Shen KF; Crain SM
Brain Res; 1995 Dec; 701(1-2):158-66. PubMed ID: 8925279
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor of cyclic AMP-dependent protein kinase blocks opioid-induced prolongation of the action potential of mouse sensory ganglion neurons in dissociated cell cultures.
Chen GG; Chalazonitis A; Shen KF; Crain SM
Brain Res; 1988 Oct; 462(2):372-7. PubMed ID: 2847853
[TBL] [Abstract][Full Text] [Related]
18. mu and delta opioid agonists at low concentrations decrease voltage-dependent K+ currents in F11 neuroblastoma x DRG neuron hybrid cells via cholera toxin-sensitive receptors.
Fan SF; Shen KF; Crain SM
Brain Res; 1993 Mar; 605(2):214-20. PubMed ID: 8386968
[TBL] [Abstract][Full Text] [Related]
19. Dynorphin prolongs the action potential of mouse sensory ganglion neurons by decreasing a potassium conductance whereas another specific kappa opioid does so by increasing a calcium conductance.
Shen KF; Crain SM
Neuropharmacology; 1990 Apr; 29(4):343-9. PubMed ID: 1971431
[TBL] [Abstract][Full Text] [Related]
20. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.
Crain SM; Shen KF
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10540-4. PubMed ID: 7479836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
